STING-associated vasculopathy with onset in infancy - A new interferonopathy

New England Journal of Medicine

Volumn 371, Issue 6, 2014, Pages 568-571

  Crow, Yanick J ^a,b,c   Casanova, Jean Laurent ^b,d  

^a Laboratories of Neurogenetics and Neuroinflammation   (France)

^b IMAGINE INSTITUTE   (France)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; C REACTIVE PROTEIN; CYCLIC AMP; CYCLIC GMP; INTERFERON REGULATORY FACTOR 3; JANUS KINASE; MEMBRANE PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; STIMULATOR OF INTERFERON GENES PROTEIN; UNCLASSIFIED DRUG; MPYS PROTEIN, HUMAN;

AICARDI GOUTIERES SYNDROME; BLOOD VESSEL INJURY; EDITORIAL; ERYTHROCYTE SEDIMENTATION RATE; GENE; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; INFANT; INFLAMMATION; INFLAMMATORY INFILTRATE; NONHUMAN; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STING ASSOCIATED VASCULOPATHY WITH ONSET IN INFANCY; TISSUE INJURY; TMEM173 GENE; UPREGULATION; VASCULAR DISEASE; FEMALE; GENETICS; MALE; MUTATION; NOTE; SKIN BLOOD VESSEL DISORDER;

FEMALE; HUMANS; INFLAMMATION; MALE; MEMBRANE PROTEINS; MUTATION; SKIN DISEASES, VASCULAR;

EID: 84905860730     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1407246     Document Type: Editorial

References (11)

1. Stetson DB, Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006;24:93-103. (Pubitemid 43077203)
2. Ishii KJ, Coban C, Kato H, et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 2006;7:40-8. [Erratum, Nat Immunol 2006;7:427.] (Pubitemid 41823867)
3. Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008; 455:674-8. [Erratum, Nature 2008;456:274.]
4. Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013;339:786-91.
5. Wu J, Sun L, Chen X, et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 2013;339:826-30.
6. Liu Y, Jesus AA, Marrero B, et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med 2014;371:507-18.
7. Lafaille FG, Pessach IM, Zhang SY, et al. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 2012;491:769-73.
8. Rice GI, del Toro Duany Y, Jenkinson EM, et al. Gain-offunction mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet 2014;46:503-9.
9. Liu L, Okada S, Kong XF, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 2011;208:1635-48.
10. Gall A, Treuting P, Elkon KB, et al. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 2012;36:120-31.
11. Crow YJ. Type I interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci 2011;1238:91-8.